Virinchi is currently trading at Rs. 60.50, up by 1.10 points or 1.85% from its previous closing of Rs. 59.40 on the BSE.
The scrip opened at Rs. 60.00 and has touched a high and low of Rs. 60.75 and Rs. 58.10 respectively. So far 18,000 shares were traded on the counter.
The BSE group 'XD' stock of face value Rs. 10 has touched a 52 week high of Rs. 85.70 on 21-Sep-2016 and a 52 week low of Rs. 29.45 on 26-Feb-2016.
Last one week high and low of the scrip stood at Rs. 68.60 and Rs. 58.10 respectively. The current market cap of the company is Rs. 108.82 crore.
The promoters holding in the company stood at 27.30%, while Institutions and Non-Institutions held 0.47% and 72.23% respectively.
Virinchi Hospitals, a 100% subsidiary of Virinchi, has reportedly opened its flagship hospitals at Banjara Hills in Hyderabad. Spread over 3.5 lakh sft of space and equipped with 600 beds, the hospital offer healthcare services across 35 specialties with focus on cardiac, orthopedics, nephrology, neurology, emergency, cancer and transplantation. To mark this occasion, the healthcare firm also unveiled 3T functional MRI and dual-energy, single-beat CT scan, which, the hospital claims, are best-in-class for neuro and cardiac imaging.
Virinchi is one of the fastest growing IT products and solutions companies with operations in India and US with annual turnover of over Rs 218 crore for the FY 2015-16. Virinchi offers IT products and solutions for US markets while offering end-to-end business solutions for Indian markets
| Company Name | CMP |
|---|---|
| TCS | 2578.45 |
| Infosys | 1311.95 |
| HCL Tech. | 1428.35 |
| Wipro | 202.40 |
| Tech Mahindra | 1504.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: